Background
==========

Primary angiitis of the central nervous system (PACNS) is a rare inflammatory brain disease with variable clinical manifestations. Only limited data exist with regard to efficient diagnostic and therapeutic algorithms and disease outcomes in children.

Aim
===

To characterize clinical features, neuroimaging findings, treatment and disease outcome in a small cohort of Czech children with PACNS.

Methods
=======

A retrospective chart review of patients referred for suspected PACNS was performed. MRI lesions detected at disease onset were classified as unilateral (UL), bilateral (BL), unifocal (F), multifocal (MF), angiography (MRA and/or conventional) positive (medium/large vessel disease) or negative (small vessel disease). According to the evolution of clinical manifestations and neuroimaging PACNS was classified as progressive or non-progressive. Data on treatment and follow-up were collected.

Results
=======

Seven female patients (all Caucasian, mean age 14,8 years, median F/U 2 years) were identified (Table). Three had favourable outcome. Four (1,2,5,7) had progressive disease resulting in significant impairment. Their mean interval from onset to diagnosis was 7 months. All 4 had multifocal lesions, 2 had negative angiography, 3 did not receive any anti-inflammatory therapy early in the disease course.

  Patient                          1                                2                                 3                         4                         5                                    6                    7
  -------------------------------- -------------------------------- --------------------------------- ------------------------- ------------------------- ------------------------------------ -------------------- -------------------
  **Age at onset (years)**         13                               1,5                               12                        16                        5,5                                  6                    15
  **Time to diagnosis (months)**   30                               5                                 1                         1,5                       12                                   1                    1,5
  **F/U (years)**                  4                                13                                5                         0,5                       2                                    1,5                  1
  **Manifestation at onset**       generalised seizures             focal seizure, stroke             seizure sensory deficit   sensory deficit, stroke   stroke                               stroke with ataxia   seizures stroke
  **MRI at onset**                 UL, MF                           UL, MF                            BL, MF                    BL,MF                     UL,MF                                UL, F                UL,MF
  **Angiography at onset**         N/D                              posit.                            posit.                    posit.                    posit.                               posit.               neg.
  **Initial therapy**              AED                              AED                               ACA                       ACA, CS                   0                                    ACA                  IVMP, AED
  **Manifestation at F/U**         seizures cognitive dysfunction   hemiparesis developmental delay   normal                    normal                    cognitive dysfunction, hemiparesis   normal               organic psychosis
  **MRI at F/U**                   BL, MF                           N/D                               N/D                       N/D                       BL, MF                               regression           BL, MF
  **Angiography F/U**              neg.                             N/D                               N/D                       N/D                       regression                           regression           neg.
  **Therapy at F/U**               AED, CS                          AED, ACA                          ACA                       CS                        ACA                                  ACA                  CYC, CS

[ACA]{.ul} - acetylsalicylic acid, [AED]{.ul} - anti-epileptic drugs, [CS]{.ul} - oral corticosteroid (prednisone or methylprednisolone), [CYC]{.ul} - cyclophosphamide, [IVMP]{.ul}- intravenous methylprednisolone, [N/D]{.ul}- not done

Conclusion
==========

Unfavourable outcome of this patient cohort reflects potential severity as well as low physicians awareness of PACNS resulting in diagnostic delay and insufficient therapy. A working group of paediatric specialists is being formed in the Czech Republic in order to establish diagnostic and therapeutic algorithms in close interdisciplinary and multicenter collaboration.
